AMPH - Amphastar Pharmaceuticals, Inc.
19.96
0.130 0.651%
Share volume: 594,582
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$19.83
0.13
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-09-2024 | 11-07-2024 | 03-03-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | 02-26-2026 | |
| Total revenue | 171.836 M | 182.394 M | 191.214 M | 186.523 M | 170.528 M | 174.414 M | 191.840 M | 183.105 M | |
| Cost of revenue | 81.736 M | 87.228 M | 89.273 M | 99.875 M | 85.277 M | 87.924 M | 93.194 M | 97.435 M | |
| Gross profit | 90.100 M | 95.166 M | 101.941 M | 86.648 M | 85.251 M | 86.490 M | 98.646 M | 85.670 M | |
| 5.62% | 7.12% | -15.00% | -1.61% | 1.45% | 14.05% | -13.15% | |||
| Operating expenses | 32.719 M | 30.937 M | 35.898 M | 31.080 M | 36.092 M | 34.071 M | 61.821 M | 39.785 M | |
| Selling general and admin | 15.676 M | 13.285 M | 14.821 M | 12.938 M | 15.996 M | 13.991 M | 39.467 M | 16.471 M | |
| Research and development | 17.043 M | 17.652 M | 21.077 M | 18.142 M | 20.096 M | 20.080 M | 22.354 M | 23.314 M | |
| Total expenses | 42.090 M | 39.949 M | 44.893 M | 41.504 M | 47.958 M | 44.306 M | 73.326 M | 50.064 M | |
| -5.09% | 12.38% | -7.55% | 15.55% | -7.61% | 65.50% | -31.72% | |||
| Operating income | 48.010 M | 55.217 M | 57.048 M | 45.144 M | 37.293 M | 42.184 M | 25.320 M | 35.606 M | |
| Ebit | 53.931 M | 55.515 M | 51.954 M | 48.095 M | 35.059 M | 43.695 M | 25.551 M | 36.121 M | |
| Pretax income | 47.876 M | 50.243 M | 47.683 M | 43.962 M | 30.862 M | 39.335 M | 21.513 M | 31.914 M | |
| 4.94% | -5.10% | -7.80% | -29.80% | 27.45% | -45.31% | 48.35% | |||
| Income tax | 4.126 M | 12.294 M | 7.254 M | 5.998 M | 5.577 M | 8.305 M | 4.163 M | 7.485 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 43.177 M | 37.949 M | 40.429 M | 37.964 M | 25.285 M | 31.030 M | 17.350 M | 24.429 M | |
| -12.11% | 6.54% | -6.10% | -33.40% | 22.72% | -44.09% | 40.80% |